Patent Assignment
Reel/Frame 053242/0608
Change of Name
Recorded: 2020-07-17
Pages: 2
Assignor
ORPHAZYME APS
Executed: 2017-11-27
Assignee
ORPHAZYME A/S
OLE MAALØES VEJ 3, COPENHAGEN N, DK-2200, DENMARK
Covered Property
(1)
Use of a Hydroximic Acid Halide Derivative in the Treatment of Neurodegenerative Diseases
Application:
14/594,817 →
Publication:
US 2015/0126551
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Sep 6, 2019
From: ORPHAZYME A/S; ORPHAZYME US, INC.
To: KREOS CAPITAL VI (UK) LIMITED
Reel/Frame 050294/0026 →
Assignment of Assignor's Interest
Jul 17, 2020
From: GREENSMITH, LINDA; BURNSTOCK, GEOFFREY
To: BIOREX RESEARCH AND DEVELOPMENT COMPANY RT (VA)
Reel/Frame 053237/0314 →
Assignment of Assignor's Interest
Jul 17, 2020
From: BIOREX KUTATO ES FEJLESZTO RT (VA); BRX RESEARCH AND DEVELOPMENT COMPANY LTD.
To: CYTRX CORPORATION
Reel/Frame 053241/0975 →
Assignment of Assignor's Interest
Jul 17, 2020
From: URBANICS, RUDOLF
To: CYTRX CORPORATION
Reel/Frame 053242/0011 →
Assignment of Assignor's Interest
Jul 17, 2020
From: CYTRX CORPORATION
To: ORPHAZYME APS
Reel/Frame 053237/0259 →
Assignment of Assignor's Interest
Jul 6, 2022
From: KEMPHARM, INC.
To: KEMPHARM DENMARK A/S
Reel/Frame 060592/0595 →
Assignment of Assignor's Interest
Jul 6, 2022
From: ORPHAZYME A/S
To: KEMPHARM, INC.
Reel/Frame 060592/0646 →
Release of Security Interest
Apr 4, 2024
From: KREOS CAPITAL VI (UK) LIMITED
To: ZEVRA DENMARK A/S (F/K/A KEMPHARM DENMARK A/S, SUCCESSOR IN INTEREST TO ORPHAZYME A/S)
Reel/Frame 067007/0706 →